Vasomedical is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products. The company operates through three wholly owned subsidiaries: VasoSolutions manages and coordinates the design; Vasomedical … Continue reading →

CIBT Education Group is an education management company focused on the global education market through the ownership and operation of a network of business, technical and language colleges. MBAIF has cooperative joint programs and representative offices in 18 countries. Its … Continue reading →

MGT Capital Investments, together with its subsidiaries (MGT Gaming, Inc., MGT Sports, Inc., and Medicsight, Inc.) is engaged in the business of acquiring, developing and monetizing intellectual property rights. MGT engages in providing imaging software and hardware devices, and consulting … Continue reading →

Amarantus BioScience is focused on developing certain biologics surrounding the intellectual property and proprietary technologies the company owns to treat and/or diagnose Parkinson’s disease, traumatic brain injury, ischemic heart disease, and other human diseases. Amarantus owns the intellectual property rights … Continue reading →

OncoSec Medical is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy for the treatment of solid tumor cancers. The company has based its core technology on its proprietary use of an electroporation platform to dramatically enhance … Continue reading →

Texas Rare Earth Resources is engaged in the acquisition, exploration, and development of mineral properties in the United States. The company’s primary focus is exploring and, if warranted, developing its Round Top rare earth minerals project located in Hudspeth County, … Continue reading →

PAR Technology offers technology solutions for restaurant operations. Its Hospitality Business provides hotel management systems with a complete suite of tools for guest management, recreation management and timeshare/condo management; as well as offers the spa industry a management application. PAR’s … Continue reading →

CytoSorbents is a critical care-focused therapeutic device company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CTSO’s purification technology removes toxic substances from blood and other bodily fluids. The company’s flagship product, CytoSorb®, … Continue reading →

ImmunoCellular Therapeutics is a clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. IMUC is conducting a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens … Continue reading →

NeoStem is engaged in the emerging cellular therapy industry, leveraging a business model that includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization (“CDMO”) providing services to clients advancing regenerative … Continue reading →